In addition to the progression of the indolent myeloproliferative state in FLT3-ITD mice by constitutively active SMO [35], these findings suggest that aberrant HH signaling may primarily play a role in promoting secondary AML. This evidence concerns the gene FLT3 and acute myeloid leukemia.